Esposito, S.; Zona, S.; Pession, A.; Iughetti, L.; Migliori, G.B.; Principi, N.
Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities. Pharmaceuticals 2021, 14, 673.
https://doi.org/10.3390/ph14070673
AMA Style
Esposito S, Zona S, Pession A, Iughetti L, Migliori GB, Principi N.
Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities. Pharmaceuticals. 2021; 14(7):673.
https://doi.org/10.3390/ph14070673
Chicago/Turabian Style
Esposito, Susanna, Stefano Zona, Andrea Pession, Lorenzo Iughetti, Giovanni Battista Migliori, and Nicola Principi.
2021. "Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities" Pharmaceuticals 14, no. 7: 673.
https://doi.org/10.3390/ph14070673
APA Style
Esposito, S., Zona, S., Pession, A., Iughetti, L., Migliori, G. B., & Principi, N.
(2021). Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities. Pharmaceuticals, 14(7), 673.
https://doi.org/10.3390/ph14070673
